Press Releases

Date Title and Summary
Toggle Summary Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care
The Radixact System will be supplied with ClearRT ® , Synchrony ® , and the VOLO™ Ultra Optimizer to enhance radiation treatment delivery precision and speed Heidelberg University Hospital is recognized worldwide for excellence in patient care and practice changing research MADISON, Wis.
Toggle Summary Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients
MADISON, Wis. , June 20, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today an agreement with TrueNorth Medical Physics LLC to provide radiation oncology departments with third-party support designed to enhance their department's capabilities.
Toggle Summary Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration
MADISON, Wis. , June 12, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the Accuray   Precision ® Treatment Planning System (TPS) has been approved by the Chinese National Medical Products Administration (NMPA).
Toggle Summary Accuray to Participate in the Jefferies Global Healthcare Conference 2024
MADISON, Wis. , May 22, 2024 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2024. The management team is scheduled to participate in a fireside chat on Wednesday, June 5, 2024 at 7:30am EDT / 4:30am PDT     A live
Toggle Summary Accuray Reports Fiscal 2024 Third Quarter Financial Results
MADISON, Wis. , May 1, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter and nine-months ended March 31, 2024 .     Third Quarter Fiscal 2024 Summary Net revenue of $101.1 million decreased 14 percent from the same period in the prior
Toggle Summary Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024
Celebrates 30 Years of Innovation Through Collaboration and the Development of Technologies That Have Helped Set the Standard of Care for the Industry MADISON, Wis. , April 25, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company is showcasing advances in
Toggle Summary Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland
  The new center is the most recent addition to the company's existing training hubs in Madison, Wisconsin ( U.S. ), Tokyo, Japan and Tianjin, China     Each facility offers a range of educational opportunities designed to advance patient care using the Accuray CyberKnife ® and Radixact ® Systems
Toggle Summary Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024
MADISON, Wis. , April 17, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2024, ended March 31, 2024 , during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on May 1, 2024 .
Toggle Summary New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System
Data Also Underscores Potential Benefits of CyberKnife System Sub-millimeter Accuracy in Preserving Quality of Life after Treatment for Prostate Cancer MADISON, Wis. , March 26, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the 2024 Radiosurgery
Toggle Summary Accuray Incorporated to Speak at 36th Annual Roth Conference
Company to Take Part in Fireside Chat Monday , March 18, 2024 at 12:30pm PST / 3:30pm EST MADISON, Wis. , March 4, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY ) announced today its participation in the 36 th Annual Roth Conference . The management team is scheduled to take part in a

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at and on the SEC's website at